學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Savannah Informatics: Innovating During the COVID-19 Pandemic
內容大綱
In February 2020, companies around the world contemplated their next moves as the pandemic news grew more grim each day. For Savannah Informatics, one of the first information services firms in Africa's health care sector, the uncertainties and immediate supply chain challenges prompted nimble moves to make sure the technology continued to perform, but also served as a call to innovate further, and add new digital offerings. This case study addresses the challenges of new product development in the health care sector, and the complexities of meeting the needs of medical providers, insurance companies, and individual customers. How would the company prioritize its next moves, and expand its technology platform? How could Savannah use its existing data on health care spending in Kenya to map out new products, including health information, telehealth and prescription services, and disease care management? And how could it distinguish its services from new competitors who also saw new demands for innovative health care solutions arising as the COVID-19 pandemic continued.